FDA
Rivastigmine Tartrate
The FDA lists this product in 40 strengths and forms.
Composition
- Active ingredients
- RIVASTIGMINE TARTRATE EQ 3MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RIVASTIGMINE TARTRATE EQ 3MG BASE · CapsuleANDA204572-002 · Prescription
- RIVASTIGMINE TARTRATE EQ 4.5MG BASE · CapsuleANDA204572-003 · Prescription
- RIVASTIGMINE TARTRATE EQ 1.5MG BASE · CapsuleANDA204572-001 · Prescription
- RIVASTIGMINE TARTRATE EQ 6MG BASE · CapsuleANDA204572-004 · Prescription
- RIVASTIGMINE TARTRATE EQ 6MG BASE · CapsuleANDA090879-004 · Prescription
- RIVASTIGMINE TARTRATE EQ 3MG BASE · CapsuleANDA090879-002 · Prescription
- RIVASTIGMINE TARTRATE EQ 4.5MG BASE · CapsuleANDA090879-003 · Prescription
- RIVASTIGMINE TARTRATE EQ 1.5MG BASE · CapsuleANDA090879-001 · Prescription
- RIVASTIGMINE TARTRATE EQ 4.5MG BASE · CapsuleANDA207797-003 · Prescription
- RIVASTIGMINE TARTRATE EQ 1.5MG BASE · CapsuleANDA207797-001 · Prescription
- RIVASTIGMINE TARTRATE EQ 6MG BASE · Capsule
At a glance
- Brand name
- Rivastigmine Tartrate
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Watson Labs
- Status
- Prescription
- FDA approval
- 8 Jan 2008
- Application
- ANDA077129-002